PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
86.40%
Net income growth above 1.5x CRWV's 7.67%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.80%
Negative yoy D&A while CRWV is 26.15%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1295.65%
Well above CRWV's 3.70% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
9.48%
SBC growth while CRWV is negative at -21.18%. John Neff would see competitor possibly controlling share issuance more tightly.
-183.70%
Both reduce yoy usage, with CRWV at -110.52%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-201.49%
Both yoy AR lines negative, with CRWV at -35.57%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.26%
Growth well above CRWV's 112.72%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-754.77%
Negative yoy while CRWV is 23.14%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-18.63%
Both yoy CFO lines are negative, with CRWV at -510.76%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
13.56%
Some CapEx rise while CRWV is negative at -74.30%. John Neff would see competitor possibly building capacity while we hold back expansions.
-61.54%
Negative yoy acquisition while CRWV stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
59.13%
Purchases growth of 59.13% while CRWV is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-46.16%
Both yoy lines are negative, with CRWV at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
92.33%
We have mild expansions while CRWV is negative at -70.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-27.34%
Both yoy lines negative, with CRWV at -200.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-61.29%
Negative yoy issuance while CRWV is 4.88%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-151.10%
We cut yoy buybacks while CRWV is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.